FAAH and migraine disorder: In an animal model of nitroglycerin-induced migraine, systemic administration of the FAAH inhibitor, URB597 attenuated nitroglycerin-induced mechanical hyperalgesia in mice and rats, indicating elevation of the AEA level by the FAAH inhibitors and a reduction in migraine pain [21,66].